Puma Biotechnology | PBYI - Interest Income


Puma Biotechnology reported $0.41 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Biogen USD 31.6M 700K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 15.92M 867K Sep/2025
Gilead Sciences USD 88M 15M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
MacroGenics USD 1.53M 114K Sep/2025
Moderna USD 73M 8M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Takeda JPY 87.87B 43.48B Dec/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025